An Ontario court ruled in favor of Alex Shved, a 37-year-old father with stage 4 melanoma, ordering the province to reconsider its refusal to cover his out-of-country cancer treatment by October 2. The judges found that denying funding for tumour-infiltrating lymphocyte (TIL) therapy was unreasonable and inadequately explained, given Shved’s dire prognosis without immediate access to the $515,000 US treatment. While Health Canada approved a commercial version of TIL therapy in August 2025, it is still under review for public funding in Canada.
Written locally by qwen2.5:14b on 2026-09-23,
using this article's own text rather than the other coverage of the
same event (that is the story summary below).
Story summary
In Ontario, The Ontario Superior Court of Justice ruled on Tuesday to quash the province’s refusal to cover out-of-country cancer treatment for Alex Shved, a 37-year-old father from Etobicoke with stage 4 melanoma. The court found that denying Mr. Shved's request for TIL therapy, which could extend his life, was unreasonable and inadequately explained by the province’s health program. Judges ordered an expedited review of the case, demanding a new decision by Oct. 2, or sooner if feasible. Justice Jean-Marc Labrosse noted that Mr. Shved is likely to die by Christmas without immediate treatment. His oncologist applied twice for OHIP coverage but was denied both times.
Written for “Ontario Cancer Treatment Rulings” on 2026-10-05,
grounded in this article and the 2 other(s) covering the same event.
The Ontario Superior Court of Justice has quashed the province’s decision to refuse to cover out-of-country cancer treatment for a father of two with stage 4 melanoma, ordering a new decision by Oct. 2.
asserted
Court → quash → Oct.
Alex Shved, a 37-year-old Etobicoke resident, had challenged the province’s decision and said Tuesday that the court’s judgment validates arguments he has put forward in his fight to see public drug coverage for tumour-infiltrating lymphocyte (TIL) therapy.
asserted
he → challenge → therapy
His physicians support Mr. Shved accessing it in Florida.
asserted
Shved → support → Florida
On Tuesday, justices Jean‑Marc Labrosse and Sharon Shore set aside decisions that denied funding for Mr. Shved’s potentially life-saving treatment, finding the justifications unreasonable and inadequately explained.
They also sent the matter back to the executive officer of the Ontario Public Drug Programs and requested a new decision with an expedited timeline, emphasizing that time is now “very tight.”
asserted
time → set → timeline
“The record discloses that he will likely be dead by Christmas if he does not receive the requested treatment within a few weeks,” the justices said.
asserted
justices → disclose → weeks
A third judge, Justice David Corbett, agreed that the decisions should be quashed.
asserted
decisions → agree → ?
However, he disagreed on the approach supported by justices Labrosse and Shore.
asserted
he → disagree → Labrosse
He said he would have directed the executive officer to recommend treatment and would have instructed OHIP’s general manager to expedite a funding decision.
asserted
he → say → decision
In August, 2025, Health Canada approved a commercial version of TIL therapy called lifileucel.
asserted
Canada → approve → therapy
But it is not available in Canada outside of clinical trials because it is still being reviewed for public funding.
asserted
it → review → funding
Mr. Shved is one of three Ontario melanoma patients who spoke with The Globe and Mail about their fears and frustrations waiting to access TIL therapy while it makes its way through the country’s complex system for funding new medical treatments.
asserted
it → speak → treatments
He applied for a provincial out-of-country program to see if it would pay for him to be treated in the U.S.
asserted
him → apply → U.S.
But he was denied and told the program isn’t intended to be used as an interim funding route for drugs that could eventually qualify for public coverage.
uncertain
that → deny → coverage
A single treatment of lifileucel costs US$515,000, not including the cost of a stay at an American hospital.
asserted
treatment → cost → hospital
So he filed for a judicial review in court in June.
asserted
he → file → June
He said the process to review medications for funding can take years and that there is no way for a Canadian patient to access the therapy.
asserted
patient → say → therapy
“What is somebody that’s got stage 4 cancer to do?” he said.
asserted
he → get → cancer
“They don’t have two years to wait for this to get approved.
asserted
this → have → years
And I think that is exactly what the judges saw.”
asserted
judges → think → what
Mr. Shved, who has a five-month-old baby and a two-year-old, has also appealed to legislators to help.
asserted
who → have → legislators
Days after having surgery on his left arm to remove a tumour, he continued to reach out to politicians.
asserted
he → have → politicians
He e-
asserted
He → e → ?
“The Court has made clear that OHIP cannot deny potentially life-saving treatment based on blanket internal policies, unsupported claims about harm to ‘the system’ or superficial reasoning,” he wrote.
uncertain
he → make → system
A spokesperson for Ms. Jones did not immediately offer comment Tuesday on the court’s decision.
asserted
spokesperson → offer → decision
Mr. Shved said he has spoken directly with Ms. Jones in the past couple of months but lamented that “she has done nothing.”
asserted
she → say → nothing
He said that makes the legal challenge his only available avenue.
asserted
challenge → say → ?
And while he said he grows discouraged from time to time when he does not receive anything in return from politicians, he remains hopeful.
asserted
he → say → politicians
He wants to help other patients “wrongly denied this treatment for absurd and unlawful reasons.”
asserted
He → want → reasons
“That’s, I think, what keeps me going and inspires me to continue.”
With reports from Kelly Grant in Toronto
asserted
what → ’ → Toronto
The Aporia
